Diprivan (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Diprivan drug offered from Fresenius Kabi USA, LLC. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: PROPOFOL
SUBSTANCE NAME: PROPOFOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, EMULSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-11-17
END MARKETING DATE: 0000-00-00


Diprivan HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDiprivan from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2009-11-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-269_01c16360-6310-4741-bd9f-c626588c858a
PRODUCT NDC: 63323-269
APPLICATION NUMBER: NDA019627

Other PROPOFOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Propofol
APP Pharmaceuticals, LLCPropofol
Fresenius Kabi USA, LLCDiprivan
General Injectables & Vaccines, IncDiprivan
General Injectables and Vaccines, IncPropofol
Hospira, Inc.PROPOFOL
Sagent Pharmaceuticalspropofol